Allogene Therapeutics Announces Expansion of Scientific Advisory Board

NEXT STORY
Valeo Pharma Announces Short Form Prospectus Unit Offering and Refiling of Its Condensed Consolidated Interim Financial Statements and Related MD&A
PREV STORY
L-DOS47 Phase II Randomized Study Advances to Second Cohort
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer

NASHUA, N.H., Aug. 30, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider ...

author_avatar
NASDAQ Market News

Biocartis Group NV: Biocartis Announces Achieving its 2018 Key Business Objectives

PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION7 January 2019, 07:01 CET Biocartis Announces Achieving its ...

author_avatar
NASDAQ Market News

Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA

NORTHVALE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc (OTCBB:ELTP) announced today ...

author_avatar
NASDAQ Market News